Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Neuroscience Neurology process Neurodegenerative disease Parkinson's disease Parkin / PARK

Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)

Price and availability

526 012 ₸

Availability

Order now and get it on Tuesday March 16, 2021

Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EP2815Y] to PARK7/DJ1 - BSA and Azide free
  • Suitable for: Flow Cyt, IP, ICC/IF, WB, IHC-P
  • Knockout validated
  • Reacts with: Mouse, Rat, Human

You may also be interested in

Product image
Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)
Product image
Anti-PGP9.5 antibody [13C4 / I3C4] - BSA and Azide free (ab180872)
Product image
Anti-PGP9.5 antibody [rUCHL1/775] (ab238074)
Product image
Anti-PGP9.5 antibody - Neuronal Marker (ab15503)

Overview

  • Product name

    Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free
    See all PARK7/DJ1 primary antibodies
  • Description

    Rabbit monoclonal [EP2815Y] to PARK7/DJ1 - BSA and Azide free
  • Host species

    Rabbit
  • Specificity

    The mouse and rat recommendation is based on the WB results. We do not guarantee IHC-P for mouse and rat.

  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    ICC/IF
    Human
    IHC-P
    Human
    IP
    Mouse
    WB
    Human
    See all applications and species data
  • Immunogen

    This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • WB: Jurkat, HeLa, NIH3T3 or 293T cell lysate. Human fetal brain; Human brain nuclear fraction tissue lysate; Mouse brain and Rat brain tissue lysates. IHC-P: Human Lung and Brain tissue. ICC/IF: PANC-1 and Jurkat cell lines. Flow Cyt: HepG2 cells. IP: Mouse brain lysate.
  • General notes

    Ab218373 is the carrier-free version of ab76008. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.

     

    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits  for antibody conjugates that are ready-to-use in as little as 20 minutes with

    ab218373 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C. Do Not Freeze.
  • Storage buffer

    pH: 7.20
    Constituent: PBS
  • Carrier free

    Yes
  • Concentration information loading...
  • Purity

    Protein A purified
  • Clonality

    Monoclonal
  • Clone number

    EP2815Y
  • Isotype

    IgG
  • Research areas

    • Neuroscience
    • Neurology process
    • Neurodegenerative disease
    • Parkinson's disease
    • Parkin / PARK
    • Signal Transduction
    • Signaling Pathway
    • G Protein Signaling
    • Small G Proteins
    • Regulators
    • Epigenetics and Nuclear Signaling
    • Chromatin Binding Proteins
    • DNA / RNA binding
    • Cancer
    • Signal transduction
    • G protein signaling
    • Small G proteins
    • Other
    • Metabolism
    • Pathways and Processes
    • Redox metabolism
    • Oxidative stress

Images

  • Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)
    Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)
    All lanes : Anti-PARK7/DJ1 antibody [EP2815Y] (ab76008) at 1/1000 dilution

    Lane 1 : Wild-type HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate
    Lane 2 : PARK7 knockout HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate
    Lane 3 : HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate
    Lane 4 : Human brain nuclear fraction tissue lysate

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) at 1/10000 dilution

    Predicted band size: 20 kDa
    Observed band size: 24 kDa
    why is the actual band size different from the predicted?



    This data was developed using ab76008, the same antibody clone in a different buffer formulation.

    Lanes 1-4: Merged signal (red and green). Green - ab76008 observed at 24 kDa. Red - loading control ab8245 observed at 36 kDa.

     ab76008 Anti-PARK7/DJ1 antibody [EP2815Y] was shown to specifically react with PARK7/DJ1 in wild-type HEK-293T cells. Loss of signal was observed when knockout cell line ab266338 (knockout cell lysate ab257016) was used. Wild-type and PARK7/DJ1 knockout samples were subjected to SDS-PAGE. ab76008 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

  • Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)
    Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)

    This IHC data was generated using the same anti-PARK7 antibody clone, EP2815Y, in a different buffer formulation (cat# ab76008).

    Immunocytochemistry/ Immunofluorescence analysis of Jurkat (Human T cell leukemia T lymphocyte) cells labeling PARK7/DJ1 with Purified ab76008 at 1:500 dilution (0.2 µg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with Ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1:200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1:1000 (2 µg/ml) dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)

    This IHC data was generated using the same anti-PARK7 antibody clone, EP2815Y, in a different buffer formulation (cat# ab76008).

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human lung cancer tissue sections labeling PARK7/DJ1 with Purified ab76008 at 1:1000 dilution (0.11 µg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use)was used as the secondary antibody. Negative control:PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

  • Flow Cytometry - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)
    Flow Cytometry - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)

    This IHC data was generated using the same anti-PARK7 antibody clone, EP2815Y, in a different buffer formulation (cat# ab76008).

     

    Flow Cytometry analysis of HepG2 (Human hepatocellular carcinoma epithelial cell) cells labeling PARK7/DJ1 with Purified ab76008 at 1:20 dilution (10 µg/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1:2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

  • Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)
    Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)

    This WB data was generated using the same anti-PARK7 antibody clone, EP2815Y, in a different buffer formulation (cat# ab76008).

    Lane 1: Wild-type HAP1 cell lysate (20 µg)
    Lane 2: PARK7/DJ1 knockout HAP1 cell lysate (20 µg) 
    Lane 3: HeLa cell lysate (20 µg)
    Lane 4: Human brain tissue lysate (20 µg)
    Lanes 1 - 4: Merged signal (red and green). Green - ab76008 observed at 24 kDa. Red - loading control, ab8245, observed at 37 kDa.

    ab76008 was shown to specifically react with PARK/DJ1 when PARK/DJ1 knockout samples were used. Wild-type and PARK/DJ1 knockout samples were subjected to SDS-PAGE. ab76008 and ab8245 (loading control to GAPDH) were both diluted 1/10 000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.

  • Immunoprecipitation - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)
    Immunoprecipitation - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)

    This IHC data was generated using the same anti-PARK7 antibody clone, EP2815Y, in a different buffer formulation (cat# ab76008).

    ab76008 (purified) at 1:20 dilution (0.5µg) immunoprecipitating PARK7/DJ1 in Mouse brain lysate.
    Lane 1 (input): Mouse brain lysate 10µg
    Lane 2 (+): ab76008 & Mouse brain lysate
    Lane 3 (-): Rabbit monoclonal IgG (ab172730) instead of ab76008 in Mouse brain lysate
    For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1:1000 dilution.
    Blocking and diluting buffer: 5% NFDM/TBST.

  • Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)
    Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)

    Immunocytochemistry/Immunofluorescence analysis of MCF-7 (human breast carcinoma) labelling PARK7/DJ1 with purified ab76008 at 1/500. Cells were fixed with 4% PFA and permeabilized with 0.1% Triton X-100. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody (Ab150077). Nuclei counterstained with DAPI (blue).

    Control: PBS only

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76008).

    This image was generated using the unpurified version of the product. 

  • Flow Cytometry - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)
    Flow Cytometry - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)

    Overlay histogram showing HepG2 cells stained with ab76008 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab76008, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1µg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in HepG2 cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76008).

    This image was generated using the unpurified version of the product. 

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)

    This IHC data was generated using the same anti-PARK7 antibody clone, EP2815Y, in a different buffer formulation (cat# ab76008).

    ab76008, at 1/250 dilution, staining PARK7/DJ1 in human brain by immunohistochemistry using paraffin-embedded tissue.

    This image was generated using the unpurified version of the product. 

    Heat mediated antigen retrieval was performed with citrate buffer pH 6 before commencing with IHC staining protocol.

  • Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)
    Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free (ab218373)

  •  
  • Product image

    Anti-PARK7/DJ1 antibody [MJF-R16 (66-5)] - BSA and Azide free (ab218374)

    Applications: WB

  •  
  • Product image

    Anti-PARK7/DJ1 antibody (ab74268)

    Applications: IHC-P

  •  
  • Product image

    Alexa Fluor® 488 Anti-PARK7/DJ1 antibody [EP2815Y] (ab203989)

    Applications: Flow Cyt, ICC/IF

  •  
  • Product image

    Anti-PARK7/DJ1 antibody [EPR19466-1-8] (ab222667)

    Applications: sELISA

  •  
  • Product image

    Alexa Fluor® 594 Anti-PARK7/DJ1 antibody [EP2815Y] (ab215102)

    Applications: ICC/IF

  •  
  • Product image

    Anti-PARK7/DJ1 antibody [malphaDJ-1/E2.19] (ab11251)

    Applications: Flow Cyt, ICC/IF, WB

  •  
  • Product image

    Anti-PARK7/DJ1 antibody [EP2816Y] (ab76241)

    Applications: Flow Cyt, IHC-P, WB

  •  
  • Product image

    Anti-PARK7/DJ1 antibody [EPR19466-105] (ab222668)

    Applications: sELISA

  •  
  • Product image

    Anti-PARK7/DJ1 antibody (ab226827)

    Applications: IHC-P, WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Indoleamine 2, 3-dioxygenase antibody [EPR20374] (ab211017)

  •  
  • Product image

    Anti-GLO1 antibody [Glo1a] (ab171121)

  •  
  • Product image

    Anti-TMPRSS2 antibody [EPR3861] (ab92323)

  •  
  • Product image

    Anti-MTCO2 antibody [12C4F12] (ab110258)

  •  
  • Product image

    Anti-BRG1 antibody [EPR3912] - BSA and Azide free (ab222230)

  •  
  • Product image

    Anti-MCP2 antibody [EPR10150] (ab155967)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.